Literature DB >> 19929794

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain.

Beatriz Mothe1, Iñaki Perez, Pere Domingo, Daniel Podzamczer, Esteban Ribera, Adrian Curran, Consuelo Viladés, Francesc Vidal, David Dalmau, Enrique Pedrol, Eugenia Negredo, José Moltó, Roger Paredes, Núria Perez-Alvarez, Jose Maria Gatell, Bonaventura Clotet.   

Abstract

We designed a multicenter cross-sectional study to describe the epidemiological characteristics of the HIV-1-infected population aged 70 years or more in our setting. 179 individuals from eight university hospitals in Barcelona, Spain, were included, representing 1.5% of HIV-1 infected subjects followed during 2008. Most subjects were male (76%) and had acquired HIV infection through sexual intercourse (87%); 69% had been diagnosed with HIV-1 after their sixties. The CD4 cell counts at HIV-1 diagnosis were < 200 cells/mm(3) in 52% of individuals, whereas this was only seen in 34% of subjects from a published cohort including younger HIV- infected adults from the same setting [1]. Most of our patients were on HAART, had undetectable HIV-1 viremia and the most recent median CD4 cell counts were >or= 350 cells/mm(3). 154 subjects had at least one comorbid condition, including dyslipidemia (54%), hypertension (36%), hyperglycemia or diabetes (30%), cardiovascular disease (23%), chronic renal failure (18%), history of neoplasia (17%) and cognitive impairment (11%). Lipodystrophy was reported in 58% of individuals. Rates of hypercholesterolemia, diabetes and cancer were higher than those reported in unselected local population (28%, 17% and 7%, respectively). The study participants were taking an average of 2.97 drugs (range 1-10) other than antiretrovirals. In conclusion, the elder population infected with HIV-1 is likely being diagnosed late and at lower CD4+ counts and is frequently affected by comorbidities and co-medication. Based on our findings, we suggest some recommendations regarding the management of this growing population.

Entities:  

Mesh:

Year:  2009        PMID: 19929794     DOI: 10.2174/157016209789973691

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  10 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 2.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

3.  Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study.

Authors:  Sauzanne Khalilieh; Ka Lai Yee; Rosa I Sanchez; Ilias Triantafyllou; Li Fan; Noha Maklad; Heather Jordan; Maureen Martell; Marian Iwamoto
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 4.  The search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: progress to date and new avenues for discovery.

Authors:  Bradley E Aouizerat; C Leigh Pearce; Christine Miaskowski
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

5.  HIV prevalence and sexual behaviour at older ages in rural Malawi.

Authors:  E Freeman; P Anglewicz
Journal:  Int J STD AIDS       Date:  2012-07       Impact factor: 1.359

6.  Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy.

Authors:  Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs
Journal:  J Int Assoc Provid AIDS Care       Date:  2013 Sep-Oct

7.  Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors.

Authors:  Assane Diouf; Amandine Cournil; Khadidiatou Ba-Fall; Ndèye Fatou Ngom-Guèye; Sabrina Eymard-Duvernay; Ibrahima Ndiaye; Gilbert Batista; Papa Mandoumbé Guèye; Pape Samba Bâ; Bernard Taverne; Eric Delaporte; Papa Salif Sow
Journal:  ISRN AIDS       Date:  2012-12-01

8.  A quarter of a century with AIDS.

Authors:  C Rodríguez-Cerdeira; M J Cruces; J A Taboada
Journal:  Open AIDS J       Date:  2011-02-03

Review 9.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.

Authors:  Nazik Elmalaika Os Husain; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-12-17

10.  Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.

Authors:  B N Mayanja; E Kabunga; B Masiira; R Lubega; P Kaleebu; J Seeley
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.